Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Neurotoxicol Teratol. 2014 Feb 22;42:77–84. doi: 10.1016/j.ntt.2014.02.004

Table 5.

BSID-II by MA exposure

Meant ± (SD)
Standard
scores		 MA Exposed Comparison Unadjusted
P-Value		 aAdjusted
P-Value
12 months (N = 94) (N= 99)
 MDI 93.16 ± 12.73 95.82 ± 13.28 0.158 0.139
(N=93) (N=99)
 PDI 87.03 ± 17.45 89.13 ± 16.79 0.397 0.035
24 months (N = 97) (N= 96)
 MDI 85.78 ± 15.76 90.21 ± 14.11 0.041 0.156
 PDI 87.14 ± 17.71 94.33 ± 14.88 0.003 0.015
36 months (N = 79) (N= 86)
 MDI 87.75 ± 12.75 88.52 ± 12.58 0.695 0.412
 PDI 90.86 ± 14.30 93.53 ± 14.51 0.235 0.657
a

Adjusted for birth weight, gender, prenatal drug exposures, socioeconomic status, and culture